Barbara Blodi, MD, discusses advancements in gene therapy for age-related macular degeneration at the ASRS annual meeting. Gene therapy is being studied in clinical trials by various companies, with the potential to be safely delivered to patients. Blodi notes that gene therapy is underway and discusses the need to determine the best way to provide this therapy to patients. This research indicates promising developments in treating age-related macular degeneration through gene therapy.
Source link
ASRS meeting highlights gene therapy advancements in AMD
